AI in clinical trials holds great promise for the entire drug development lifecycle. However, any new technology should always be implemented with the end goal in mind—helping patients.

Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Evidence-based nutritional recommendations address the health impact of suboptimal nutritional status. Efficacy randomized controlled trials (RCTs) have traditionally been the preferred method for ...

Clinical trial sponsors expanding studies across Europe often face complex regulatory pathways for sample testing, ...

As a type of short noncoding RNAs, microRNA (miRNA) undoubtedly plays a crucial role in cancer development. Since the discovery of the identity and clinical functions of miRNAs, over the past few ...

The clinical trial landscape is continually adapting its focus on patient-centric practices to improve clinical trial participation by reducing patients' burden. Over the past few years, this shift ...

Stakeholders asked the US Food and Drug Administration for more examples in comments on a recently issued guidance on the use of overall survival as an endpoint in oncology drug clinical trials. They ...

Scott Piergrossi, president of creative for the healthcare industry naming giant Brand Institute, estimated that acronyms only make up about one-third of the trial names the institute helps create.

The unprecedented expansion of approved oncology therapies has prolonged survival and transformed the prognosis for many patients diagnosed with cancer. However, cancer treatments may be associated ...

Clinical trials are the engine of progress in cancer care. Yet despite their importance, most patients with cancer never ...